William Pao

William Pao

Director/Board Member at IMMUNOCORE HOLDINGS PLC

Net worth: - $ as of 2026-05-30

59 year
Health Technology
Consumer Services
Commercial Services

Profile

William Pao is the founder of Revelio Therapeutics, Inc., founded in 2024, where he holds the title of Chief Executive Officer.
Dr. Pao is also the founder of My Cancer Genome.
Current jobs include Director at Transcelerate Biopharma, Inc., Director at Obsidian Therapeutics, Inc., Director at Alentis Therapeutics AG, and Independent Non-Executive Director at Immunocore Holdings Plc starting in 2025.
Former jobs include Professor and Director of the Hematology & Oncology Division at Vanderbilt University, Director at the American Association for Cancer Research, Director of Personalized Cancer Medicine at The Vanderbilt-Ingram Cancer Center, Chief Development Officer and Executive Vice President at Pfizer Inc. from 2022 to 2023, and Head of Pharma Research & Early Development at Roche Holding AG and F.
Hoffmann-La Roche Ltd. from 2014 to 2022.
Education includes undergraduate studies at Harvard University and a doctorate from Yale University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-05-26 0 ( -.--% ) - $ 2026-05-30

William Pao active positions

CompaniesPositionStart
IMMUNOCORE HOLDINGS PLC Director/Board Member 2025-02-24
Director/Board Member -
Director/Board Member -
Director/Board Member -
Chief Executive Officer 2024-04-30

Former positions of William Pao

CompaniesPositionEnd
PFIZER INC. Corporate Officer/Principal 2023-08-14
ROCHE HOLDING AG Corporate Officer/Principal 2022-03-17
Corporate Officer/Principal 2022-02-28
My Cancer Genome
Founder -
░░░░░░░░ ░░░░░░░░░░░ ░░░ ░░░░░░ ░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ -
See the detail of William Pao's experience

Training of William Pao

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

38

1st degree connections

14

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies14

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Consumer Services

Commercial Services

Health Services

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

My Cancer Genome

Electronic Technology